Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can Fulgent Genetics Stock Rebound?

TheMotleyFool

0 0

Can a diagnostics company that makes most of its money from coronavirus tests keep growing in a post-pandemic environment? Fulgent Genetics (NASDAQ: FLGT) shares are still far below their peak in February, despite reporting record revenue in the fourth quarter.

Could this stock deliver market-beating gains over the long run, or are its new shareholders setting themselves up for heartbreak once the COVID-19 vaccine supply catches up with demand? To find out where the company is headed, let's start with a quick look at its recent accomplishments.

Image source: Getty Images.

Source Fool.com

Like: 0

FLGT

Share